The largest database of trusted experimental protocols

6 protocols using kpl 1

1

Inhibition of A. phagocytophilum Adherence to PSGL-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine if AipA was important for A. phagocytophilum recognition of sLex-capped PSGL-1, DC organisms were incubated with antiserum targeting AipA1–87, AipA249–355, OmpA (Ojogun et al., 2012 (link)), or preimmune control serum as described above. Next, the treated bacteria were incubated with PSGL-1 CHO cells or untransfected CHO cells for 1 h, followed by two rounds of washing with PBS to remove unbound bacteria, and enumeration of bound organisms using spinning disk confocal microscopy as described (Troese et al., 2009 (link)). As positive controls for inhibition of bacterial adherence to sLex-capped PSGL-1, PSGL-1 CHO cells were incubated with the PSGL-1 N-terminus-specific antibody, KPL-1 (BD Biosciences, San Jose, CA), or the sLex-specific antibody, CSLEX1 (BD Biosciences) for 30 min prior to the addition of bacteria. Mouse IgG and mouse IgM served as isotype controls for KPL-1 and CSLEX1, respectively.
+ Open protocol
+ Expand
2

Evaluating Neutrophil Adhesion Markers in IVIG Infusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood into EDTA or ACD drawn immediately pre- and 24±4 hours post- infusion was evaluated by flow cytometry for adhesion markers on CD16b+ (ID3, Beckman Coulter) neutrophils: activated Mac-1 (CBRM1/5, eBioscience) or activated β2 integrin (ab13219, abcam), Mac-1 (ICRF44, BD Pharmingen), CD44 (G44-26, BD Pharmingen), E-selectin-Fc chimera (R&D Systems), L-selectin (DREG-56, eBioscience), LFA-1 (HI111 BD Pharmingen), and PSGL-1 (KPL-1, BD Pharmingen). Activated Mac-1 Ab detects the functionally active form of Mac-1(was performed on 200–800 mg/kg cohorts) and activated β2 integrin recognizes the high affinity conformation of β2 integrin, the β subunit of LFA-1 and Mac-1 (was performed on 100 mg/kg cohort).
With late afternoon or evening study drug administration, samples were stored overnight as needed (range 8–24 hours) at 4°C prior to analysis. When stored overnight, all paired pre-IVIG and 24 hour post-IVIG samples per patient were stored for uniform lengths of time. No adhesion markers except activated Mac-1 show expression increase at 24 hr compared to immediate analysis (Figure 1B). Since the time interval to analysis was constant for each subject’s two samples, the ratio between the two samples (Figure 1A) was unaffected by storage.
+ Open protocol
+ Expand
3

Lentiviral Knockdown of PSGL-1 in T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentiviral vectors carrying shRNAs against PSGL-1 were purchased from Sigma-Aldrich. Virion particles were assembled by cotransfecting HEK293T cells with pHCMV-G, pCMV-ΔR8.2, and lentiviral vectors. Supernatant was collected and used to transduce Jurkat T cells. Cells were selected in puromycin. PSGL-1 knockdown was confirmed by surface staining with an anti–PSGL-1 antibody (KPL-1; BD Pharmingen). Lentiviral vector-mediated ShRNA knockdown of PSGL-1 in primary CD4 T cells was performed as described previously (46 (link)). In brief, blood resting CD4 T cells were purified by negative depletion, transiently stimulated with anti-CD3/CD28 beads, and then transduced with the lentiviral vectors carrying shRNAs against PSGL-1. Additional details of shRNA knockdown and analysis are provided in SI Appendix, Materials and Methods.
+ Open protocol
+ Expand
4

Quantifying Immune Cell Surface Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression of PSGL-1, DC-SIGN and SCARB2 was assessed with flow cytometry. The following antibodies or isotype-matched IgG were used (clone numbers and resources are given in parentheses): PE-anti-DC-SIGN (eB-h209; eBioscience) and purified anti-PSGL-1 monoclonal antibody (KPL-1; BD Pharmingen), followed by staining with secondary anti-mouse antibodies. Stained cells were detected with an LSRII flow cytometer (BD Biosciences Pharmingen) and analyzed with FlowJo 7.6.1 software (TreeStar Inc.).
+ Open protocol
+ Expand
5

Western Blotting Analysis of Leukocyte Adhesion Molecules

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein samples were boiled in reducing Laemmli loading buffer (Boston BioProducts) and then resolved on 7.5% SDS-PAGE electrophoresis gels (Bio-Rad). Resolved proteins were transferred to PVDF membranes (Bio-Rad) and blocked with 10% milk and 0.1% Tween20 in TBS. Western blots were probed with primary antibodies (1 μg/mL), followed by incubation with HRP-conjugated secondary antibodies (Southern Biotech). Expression of sLeX, CD44, PSGL-1, CD43, MPO and L-selectin were assessed using the mAbs HECA-452 (Biolegend), 2C5 (R&D Systems), KPL-1 (BD Biosciences), 1G10 (BD Biosciences), 2C7 (Abcam) and LAM1-116 (Santa Cruz Biotechnology), respectively. For E-Ig blotting, membranes were incubated with E-Ig (1 μg/mL) suspended in TBS 0.1% Tween20 containing 2 mM CaCl2, followed by incubation with rat anti-mouse CD62E mAb (R&D Systems) and then goat anti-rat IgG-HRP (Southern Biotech). Antigens were detected by chemiluminescence using Lumi-Light Western blotting substrate (Roche).
+ Open protocol
+ Expand
6

Flow Cytometry and Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed on a FACS Canto II (BD Biosciences) and analyzed using FlowJo Software (Treestar). Cells were stained with antibodies to CD3, CD4 (OKT4), CXCR4 (12G5), VLA-4 (9F10) and CD15s (CSLEX1) from BD biosciences, and HECA452, CD45 (2D1), CD44 (BJ14), CD162 (KPL-1), CD43 (CD43-10G7), and FoxP3 (206D) from Biolegend. Staining with mouse E-selectin Ig chimera (RnD Systems) was detected with either anti-His FITC (Bethyl Laboratories) for flow cytometry or secondary rat anti-mouse CD62E (BBIG-E4, RnD Systems) followed by goat anti-rat IgG HRP (Southern Biotech) for western analyses.
Lysates were made from cells by sonication/vortexing in buffer containing 50 mM Tris, 150 mM NaCl, 20 ug/ml phenylmethanesulfonyl fluoride (PMSF), 0.2% NaN3, protease inhibitor cocktail (Roche), 2% NP40, and 0.2% SDS. Precleared lysates were incubated antibodies to CD43 (1G10, L60, BD Biosciences; 20819, Santa Cruz Biotechnology), PSGL-1 (KPL-1, BD Biosciences; 20929, Santa Cruz Biotechnology), or CD44 (515, BD Biosciences; 2C5, RnD systems). Protein was immunoprecipitated with Protein-G agarose (Life Technologies). Western Blots were run with Reducing SDS-PAGE gels (Bio-Rad).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!